Effects of Dry Needling in Athletes With Subacromial Pain Syndrome

May 27, 2026 updated by: Carlos Alberto Villarón Casales, Universidad Europea de Valencia

Effects of Dry Needling on Proprioception, Dynamic Stability, Strength, Pain Perception, and Disability in Athletes With Subacromial Pain Syndrome

The goal of this clinical trial is to evaluate whether dry needling combined with therapeutic exercise improves shoulder proprioception in amateur athletes with subacromial pain syndrome. The study will also assess its effects on dynamic stability, strength, pain, and functional disability.

The main questions this study aims to answer are:

Does dry needling improve shoulder proprioception compared with therapeutic exercise alone? Does dry needling improve dynamic shoulder stability and muscle strength? Does dry needling reduce pain and upper limb disability?

Researchers will compare a group receiving dry needling plus therapeutic exercise with a group performing therapeutic exercise alone to determine whether the combined intervention produces better outcomes.

Participants will:

Be randomly assigned to one of the two treatment groups. Perform a home-based therapeutic exercise program for 3 weeks. Complete assessments of proprioception, dynamic stability, strength, pain, and functional disability before and after the intervention.

Study Overview

Status

Not yet recruiting

Detailed Description

Subacromial pain syndrome (SAPS) is one of the most common causes of shoulder pain and dysfunction in both the general population and athletes involved in repetitive upper-limb activities. In sports requiring overhead movements, throwing actions, or repetitive shoulder loading, the increased mechanical demand placed on the glenohumeral joint may contribute to functional impairments, persistent pain, and reduced athletic performance.

Several studies have reported proprioceptive deficits and sensorimotor control alterations in individuals with SAPS. These impairments may affect joint position sense, muscular coordination, and dynamic shoulder stability, potentially contributing to symptom persistence and increasing the risk of recurrent injury. Previous research has also associated proprioceptive deficits with higher pain intensity, functional disability, and reduced neuromuscular control.

Proprioception plays a fundamental role in sensory integration and in the regulation of precise and coordinated shoulder movements. Altered afferent input from muscular and articular structures may impair dynamic stabilization mechanisms and compromise upper-limb function during sports activities.

Dry needling is a minimally invasive physiotherapy technique widely used for the treatment of myofascial trigger points. Previous studies have demonstrated positive effects of dry needling on pain and functional disability in individuals with subacromial pain syndrome. In addition, research conducted in other joints has suggested that dry needling may influence motor control, postural stability, and proprioceptive mechanisms.

Despite the growing clinical interest in this intervention, there is currently limited evidence regarding the effects of dry needling on shoulder proprioception and sensorimotor variables in individuals with SAPS, particularly in athletic populations. Therefore, further investigation is needed to determine whether adding dry needling to a therapeutic exercise program may provide additional benefits for neuromuscular control and shoulder function.

The primary aim of this clinical trial is to evaluate the effectiveness of dry needling combined with therapeutic exercise on shoulder proprioception in amateur athletes with subacromial pain syndrome. Additionally, the study will assess the potential effects of the intervention on dynamic stability, shoulder isometric strength, pain perception, and upper-limb functional disability.

A randomized controlled trial with two parallel groups will be conducted. Participants will be randomly assigned in a 1:1 ratio to:

an experimental group receiving dry needling combined with therapeutic exercise, or a control group receiving therapeutic exercise alone.

The intervention period will last 3 weeks. Participants in the experimental group will receive two dry needling sessions separated by a 10-day interval. The technique will be administered by an experienced physiotherapist with specialized training in dry needling, following a predefined protocol based on the available scientific literature.

The intervention will target myofascial trigger points located in scapulohumeral muscles commonly associated with shoulder pain and subacromial pain syndrome. Trigger points will be identified through standardized clinical examination procedures.

Both groups will perform a structured home-based therapeutic exercise program focused on muscular strengthening, neuromuscular control, and shoulder function. Participants will receive individualized instructions, and adherence to the exercise program will be monitored using follow-up records.

Outcome assessments will be performed by an evaluator blinded to group allocation in order to minimize measurement bias. Measurements will be collected at different time points throughout the study to evaluate changes in proprioception, dynamic stability, muscular strength, pain, and functional disability.

This study aims to provide clinical evidence regarding the potential role of dry needling as an adjunct to therapeutic exercise in the management of sensorimotor and functional impairments associated with subacromial pain syndrome in athletic populations. The findings may contribute to the development of more effective therapeutic strategies aimed at improving shoulder function and optimizing functional recovery in athletes with this condition.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Valencia
      • Valencia, Valencia, Spain, 46006
        • Clínica Dr Villarón
        • Contact:
        • Contact:
          • Carlos A Villarón Casales, Clinical Director
          • Phone Number: + 34 611 68 62 26
          • Email: cvillaron@gmail.com
        • Principal Investigator:
          • Carlos A Villarón Casales, PT, MSc, PhD
        • Sub-Investigator:
          • Pablo Taberner Mortes, PT, MSc
        • Sub-Investigator:
          • Alejandro Sendín Magdalena, PT, MSc, PhD
        • Sub-Investigator:
          • Mathilde Conde Aparicio, PT, MSc
        • Sub-Investigator:
          • Lucia Ortega Pérez de Villar, PT, MSc, PhD
        • Sub-Investigator:
          • Javier Fenollar Cortes, PT, MSc, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Men and women aged between 18 and 40 years.
  • Clinical diagnosis of subacromial pain syndrome (SAPS) according to the Dutch Orthopaedic Association criteria: presence of a painful arc and at least two positive tests among the following: Hawkins-Kennedy test, Neer sign, Jobe test, Drop Arm test, or Gerber test.
  • Participation in sports involving predominant upper-limb activity between 2 and 4 hours per week.

Exclusion Criteria:

  • Previous surgery involving the upper extremities.
  • Diagnosis of specific shoulder pathologies other than SAPS at the time of the study.
  • Receipt of medical or physiotherapy treatment within the month prior to the intervention.
  • Needle phobia or refusal to receive dry needling treatment.
  • Presence of vestibular disorders, balance impairments, or vascular alterations that could interfere with study measurements.
  • Confirmed or suspected pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dry Needling + Therapeutic Exercise

Participants assigned to the experimental group will receive a combined intervention consisting of dry needling and a structured home-based therapeutic exercise program over a 3-week period.

Dry needling will be applied to active myofascial trigger points identified in scapulohumeral muscles commonly associated with subacromial pain syndrome, including the supraspinatus, infraspinatus, subscapularis, teres minor, teres major, and anterior and middle deltoid muscles. Trigger points will be identified through standardized clinical examination based on the presence of a palpable taut band, a hypersensitive spot within the taut band, reproduction of the participant's recognizable pain, and local twitch response.

The intervention will be performed by a physiotherapist with more than 10 years of clinical experience and certified training in dry needling techniques. A standardized dry needling protocol based on previously published methods will be used. After skin disinfection with chlorhe

Dry needling will be applied to active myofascial trigger points identified in scapulohumeral muscles commonly associated with subacromial pain syndrome, including supraspinatus, infraspinatus, subscapularis, teres minor, teres major, and anterior and middle deltoid muscles. Trigger points will be identified through standardized clinical examination. The intervention will be performed by an experienced physiotherapist using sterile disposable needles and a standardized fast in-fast out technique. Participants will receive two dry needling sessions separated by a 10-day interval.
Participants will perform a structured home-based therapeutic exercise program focused on shoulder strengthening, neuromuscular control, and sensorimotor function using elastic resistance bands. The exercise program will be performed three times per week for 3 weeks following a standardized protocol. Participants will receive individualized instruction, exercise materials, and adherence monitoring throughout the intervention period.
Active Comparator: Therapeutic Exercise

Participants assigned to the control group will receive a structured home-based therapeutic exercise program over a 3-week period without dry needling intervention.

The exercise program will focus on shoulder strengthening, neuromuscular control, and sensorimotor function using elastic resistance bands. Participants will perform the exercises three times per week for 3 weeks following a standardized protocol.

All participants will receive individualized in-person instruction from a physiotherapist to ensure correct exercise execution. Participants will also receive the necessary exercise materials and an adherence diary to record compliance throughout the intervention period.

The therapeutic exercise program administered in the control group will be identical to the exercise intervention performed in the experimental group in terms of exercise type, frequency, duration, supervision, and home-based format. No invasive procedures or sham dry needling interventions will be performed i

Participants will perform a structured home-based therapeutic exercise program focused on shoulder strengthening, neuromuscular control, and sensorimotor function using elastic resistance bands. The exercise program will be performed three times per week for 3 weeks following a standardized protocol. Participants will receive individualized instruction, exercise materials, and adherence monitoring throughout the intervention period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder Proprioception Assessed With the Joint Position Sense Tes
Time Frame: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Shoulder proprioception will be evaluated using the Joint Position Sense (JPS) test. Participants will actively reproduce a predefined shoulder position, and the absolute angular repositioning error in degrees will be recorded using an inclinometer. Lower values indicate better proprioceptive accuracy.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamic Shoulder Stability Assessed With the Upper Quarter Y Balance Test
Time Frame: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Dynamic shoulder stability will be assessed using the Upper Quarter Y Balance Test (YBT-UQ). Reach distances in the medial, inferolateral, and superolateral directions will be recorded in centimeters. Greater reach distance indicates better dynamic stability and sensorimotor performance.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Isometric Shoulder Strength Assessed With Handheld Dynamometry
Time Frame: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Isometric strength of the shoulder abductors and rotator muscles will be measured using a handheld dynamometer during maximal voluntary isometric contractions. Higher force values indicate greater muscle strength.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Pain Intensity Assessed With the Numeric Rating Scale
Time Frame: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Lower scores indicate lower pain intensity.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Upper Limb Disability Assessed With the Disabilities of the Arm, Shoulder and Hand Questionnaire
Time Frame: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Functional disability of the upper limb will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. Higher scores indicate greater disability and functional impairment.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Carlos A Villaron Casales, PT, MSc, PhD, Universidad Europea de Valencia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

May 27, 2026

First Submitted That Met QC Criteria

May 27, 2026

First Posted (Actual)

June 2, 2026

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

May 27, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Individual participant data may be shared in the future in anonymized form upon reasonable request and in accordance with ethical approval, participant consent, and applicable data protection regulations. A definitive data sharing plan has not yet been established.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Subacromial Pain Syndrome

Clinical Trials on Dry needling

Subscribe